000 01405nam  2200361zi 4500
0019.870481
003CaOODSP
00520240823083414
006m     o  d f      
007cr cn|||||||||
008190322t20192019onc     o    f000 0 eng d
020 |a9780660302379
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH164-273/2019E-PDF
24500|aGuidance document : |bregulatory requirements for drug identification numbers (DINs).
250 |a[2019/05/03 edition].
264 1|aOttawa, ON : |bHealth Canada = Santé Canada, |c2019.
264 4|c©2019
300 |a1 online resource (27 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Ligne directrice : exigences réglementaires associées à une identification numérique attribuée à une drogue (DIN).
500 |aCover title.
500 |a"Date adopted: 2019/05/03. Effective date: 2019/05/03."
500 |a"Publication date: May 2019."
500 |a"Pub.: 180925."
69207|2gccst|aDrugs
7101 |aCanada. |bHealth Canada.
77508|tLigne directrice : |w(CaOODSP)9.870482
794 |tGuidance document : |b[2019/06/19 edition]|w(CaOODSP)9.874552
85640|qPDF|s304 KB|uhttps://publications.gc.ca/collections/collection_2019/sc-hc/H164-273-2019-eng.pdf